123 related articles for article (PubMed ID: 2341301)
1. AFTR: a fifth human B-cell-specific surface antigen.
Pesando JM; Stucki MA
Hum Immunol; 1990 Mar; 27(3):193-207. PubMed ID: 2341301
[TBL] [Abstract][Full Text] [Related]
2. Distinct human leukemia-associated cell surface glycoprotein GP160 defined by monoclonal antibody SN6.
Haruta Y; Seon BK
Proc Natl Acad Sci U S A; 1986 Oct; 83(20):7898-902. PubMed ID: 3464004
[TBL] [Abstract][Full Text] [Related]
3. A cytotoxic monoclonal antibody detecting a novel B cell membrane antigen expressed predominantly on cells bearing surface membrane immunoglobulin.
Jephthah J; Terasaki PI; Hofman F; Wolde-Marian W; Peter JB; Billing R
Blood; 1984 Feb; 63(2):319-25. PubMed ID: 6607081
[TBL] [Abstract][Full Text] [Related]
4. Identification of several cell surface proteins of non-T, non-B acute lymphoblastic leukemia by using monoclonal antibodies.
Quackenbush EJ; Letarte M
J Immunol; 1985 Feb; 134(2):1276-85. PubMed ID: 3155538
[TBL] [Abstract][Full Text] [Related]
5. A monoclonal antibody defining human B cell differentiation antigen (HLB-1 antigen).
Kasai K; Koshiba H; Ishii Y; Kikuchi K
Microbiol Immunol; 1983; 27(1):51-64. PubMed ID: 6408355
[TBL] [Abstract][Full Text] [Related]
6. Preparation and characterization of monoclonal antibodies recognizing three distinct differentiation antigens (BL1, BL2, BL3) on human B lymphocytes.
Wang CY; Azzo W; Al-Katib A; Chiorazzi N; Knowles DM
J Immunol; 1984 Aug; 133(2):684-91. PubMed ID: 6429242
[TBL] [Abstract][Full Text] [Related]
7. Human Lyb-2 homolog CD72 is a marker for progenitor B-cell leukemias.
Schwarting R; Castello R; Moldenhauer G; Pezzutto A; von Hoegen I; Ludwig WD; Parnes JR; Dörken B
Am J Hematol; 1992 Nov; 41(3):151-8. PubMed ID: 1384316
[TBL] [Abstract][Full Text] [Related]
8. Monoclonal antibody NU-B1 reacts with novel antigen on human B cells in mantle and marginal zones distinct from known CD molecules.
Matsuo Y; Sugimoto A; Kuwahara K; Watanabe Y; Sakata A; Sakaguchi N; Sagawa K; Orita K
Tissue Antigens; 1998 Nov; 52(5):422-9. PubMed ID: 9864031
[TBL] [Abstract][Full Text] [Related]
9. Detailed studies on expression and function of CD19 surface determinant by using B43 monoclonal antibody and the clinical potential of anti-CD19 immunotoxins.
Uckun FM; Jaszcz W; Ambrus JL; Fauci AS; Gajl-Peczalska K; Song CW; Wick MR; Myers DE; Waddick K; Ledbetter JA
Blood; 1988 Jan; 71(1):13-29. PubMed ID: 3257143
[TBL] [Abstract][Full Text] [Related]
10. BP-3 alloantigen. A cell surface glycoprotein that marks early B lineage cells and mature myeloid lineage cells in mice.
McNagny KM; Cazenave PA; Cooper MD
J Immunol; 1988 Oct; 141(8):2551-6. PubMed ID: 3262662
[TBL] [Abstract][Full Text] [Related]
11. An anti-CD72 immunotoxin against therapy-refractory B-lineage acute lymphoblastic leukemia.
Myers DE; Uckun FM
Leuk Lymphoma; 1995 Jun; 18(1-2):119-22. PubMed ID: 8580813
[TBL] [Abstract][Full Text] [Related]
12. In vivo efficacy of B43 (anti-CD19)-pokeweed antiviral protein immunotoxin against BCL-1 murine B-cell leukemia.
Uckun FM; Chelstrom LM; Irvin JD; Finnegan D; Gunther R; Young J; Kuebelbeck V; Myers DE; Houston LL
Blood; 1992 May; 79(10):2649-61. PubMed ID: 1375109
[TBL] [Abstract][Full Text] [Related]
13. Identification and characterization of a new surface membrane antigen found predominantly on malignant B lymphocytes.
Gingrich RD; Dahle CE; Hoskins KF; Senneff MJ
Blood; 1990 Jun; 75(12):2375-87. PubMed ID: 1693529
[TBL] [Abstract][Full Text] [Related]
14. Ki-B5: a monoclonal antibody unrelated to CD45 recognizes normal and neoplastic human B cells in routine paraffin sections.
Hansmann ML; Wacker HH; Gralla J; Lumbeck H; Kossmahl M; Heidebrecht HJ; Radzun HJ; Parwaresch MR
Blood; 1991 Feb; 77(4):809-17. PubMed ID: 1704265
[TBL] [Abstract][Full Text] [Related]
15. Three distinct antigen systems on human B cell subpopulations as defined by monoclonal antibodies.
Takami T; Ishii Y; Yuasa H; Kikuchi K
J Immunol; 1985 Feb; 134(2):828-34. PubMed ID: 3917477
[TBL] [Abstract][Full Text] [Related]
16. Monoclonal antibody against a "Pan-T-cell" antigen expressed by thymocytes, peripheral T-lymphocytes and T-cell leukemias.
Carrel S; Gross N; Heumann D; Sekaly RP; Girardet C; Schmidt-Kessen A; Mach JP
Mol Immunol; 1984 Oct; 21(10):831-40. PubMed ID: 6438496
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of ricin A chain-containing immunotoxins directed against CD19 and CD22 antigens on normal and malignant human B-cells as potential reagents for in vivo therapy.
Ghetie MA; May RD; Till M; Uhr JW; Ghetie V; Knowles PP; Relf M; Brown A; Wallace PM; Janossy G
Cancer Res; 1988 May; 48(9):2610-7. PubMed ID: 2451562
[TBL] [Abstract][Full Text] [Related]
18. A novel non-lineage antigen on human leucocytes: characterization with two CD-48 monoclonal antibodies.
Henniker AJ; Bradstock KF; Grimsley P; Atkinson MK
Dis Markers; 1990; 8(4):179-90. PubMed ID: 2088634
[TBL] [Abstract][Full Text] [Related]
19. Human lymphocyte differentiation antigens HB-10 and HB-11. I. Ontogeny of antigen expression.
Tedder TF; Clement LT; Cooper MD
J Immunol; 1985 May; 134(5):2983-8. PubMed ID: 3156922
[TBL] [Abstract][Full Text] [Related]
20. Distribution of a hematopoietic-specific differentiation antigen of K562 cells in the human myeloid and lymphoid cell lineages.
Clarke BJ; Liao SK; Leeds C; Soamboonsrup P; Neame PB
Cancer Res; 1987 Aug; 47(16):4254-9. PubMed ID: 3475169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
